Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review George KassianosOsamah BarasheedSelim Badur Review Open access 06 July 2023 Pages: 2193 - 2219
Correction to: Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review George KassianosOsamah BarasheedSelim Badur Publisher Correction Open access 04 October 2023 Pages: 2221 - 2222
Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review Mayan GilboaNadav BaharavDafna Yahav Review Open access 13 September 2023 Pages: 2223 - 2240
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults Louise MurdochKaren Quanthe C4591030 Clinical Trial Group Original Research Open access 12 September 2023 Pages: 2241 - 2258
Misoprostol-Induced Fever and Unnecessary Antibiotic Prescribing: A Retrospective Study Laila Carolina Abu EsbaGhada Al MardawiHusam I. Ardah Original Research Open access 13 September 2023 Pages: 2259 - 2268
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial F. D. Richard HobbsHugh MontgomeryMark T. Esser Original Research Open access 26 September 2023 Pages: 2269 - 2287
Clusters of SARS-CoV-2 Infection Across Six Schools for Students with Intellectual and Developmental Disabilities Michael GemmellTyler WalshJason G. Newland Brief Report Open access 13 September 2023 Pages: 2289 - 2294
A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category Ming M. ZhangRyan W. StevensChristina G. Rivera Brief Report Open access 26 September 2023 Pages: 2295 - 2305
Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study Caroline R. PerryNicole E. Scangarella-OmanDavid A. Lewis Study Protocol Open access 26 September 2023 Pages: 2307 - 2320
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1 Judith A. AbergBronagh ShepherdAllan R. Tenorio Original Research Open access 26 September 2023 Pages: 2321 - 2335